Elizabeth Baker,
Pharmaceutical Policy Program Director
Elizabeth Baker, Esq., is the pharmaceutical policy program director for the Physicians Committee for Responsible Medicine, a U.S. based organization working for more effective, efficient and ethical research and testing. Ms. Baker focuses on modernizing drug development to save human and animal lives by integrating nonclinical methods that are more relevant to human biology. Ms. Baker leads the Nonclinical Innovation and Patient Safety Initiative (NIPSI), a broad group of drug development stakeholders working to advance human relevant technologies. Ms. Baker has authored numerous op eds, science blogs, regulatory petitions and manuscripts, including publication in Drug Discovery Today, ALTEX, The Hill, STAT News, the Food and Drug Law Institute Policy Forum, the North Carolina Central University School of Law Biotechnology and Pharmaceutical Law Review and the Physicians Committee’s Good Science Digest regarding FDA policy and innovative human biology-based science for drug development.
|
|
|
